文献速递呼吸道感染呼吸危重症与机械通气

新脓毒症定义(Sepsis-3)与社区获得性肺炎死亡率:一项验证与临床决策研究

New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

本研究为西班牙两家大学医院的成人社区获得性肺炎队列研究,共纳入6874例患者,院内死亡442例(6.4%)。比较SIRS、qSOFA、CRB、mSOFA、CURB-65和PSI等评分对院内死亡的判别与临床效用,发现qSOFA和CRB优于SIRS,PSI作为综合评估工具的决策辅助性能最佳,Sepsis-3流程图能更好识别高死亡风险患者。

要点

  • qSOFA和CRB在急诊CAP患者中优于SIRS,可作为快速筛查工具。
  • PSI在综合评估工具中决策辅助性能最佳,优于mSOFA和CURB-65。
  • Sepsis-3流程图能更好识别CAP高死亡风险患者。

核心结论

  • qSOFA和CRB优于SIRS,作为急诊CAP患者快速工具具有更好的临床效用。
  • 在综合评估工具中,PSI具有最佳的决策辅助工具特性。
  • Sepsis-3流程图能更好地识别高死亡风险患者。

研究设计与样本

  • 研究为队列研究,纳入西班牙两家大学医院的成人社区获得性肺炎患者。
  • 共纳入6874例患者,院内死亡442例(6.4%)。
  • 使用急诊科数据计算SIRS、qSOFA、CRB、mSOFA、CURB-65和PSI评分。
  • 采用决策曲线分析评估各评分的临床有用性,主要结局为院内死亡。

主要发现

  • SIRS判别能力最差,依次为qSOFA、CRB、mSOFA、CURB-65和PSI。
  • qSOFA和mSOFA对院内死亡率的总体高估和校准不良更明显。
  • SIRS的净获益低于qSOFA和CRB,显著增加过度治疗风险,与「全部治疗」策略相当。
  • PSI在死亡率方面净获益高于mSOFA和CURB-65,而mSOFA在考虑死亡率/ICU入住时似乎更适用。
  • Sepsis-3流程图能更好地识别高死亡风险患者。

临床怎么用

  • 急诊CAP患者可优先使用qSOFA或CRB进行快速风险筛查。
  • 综合评估时PSI可作为决策辅助工具,尤其针对死亡率预测。
  • Sepsis-3流程图有助于识别高死亡风险CAP患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: The Sepsis-3 Task Force updated the clinical criteria for sepsis, excluding the need for systemic inflammatory response syndrome (SIRS) criteria. The clinical implications of the proposed flowchart including the quick Sequential (Sepsis-related) Organ Failure Assessment (qSOFA) and SOFA scores are unknown. OBJECTIVES: To perform a clinical decision-making analysis of Sepsis-3 in patients with community-acquired pneumonia. METHODS: This was a cohort study including adult patients with community-acquired pneumonia from two Spanish university hospitals. SIRS, qSOFA, the Confusion, Respiratory Rate and Blood Pressure (CRB) score, modified SOFA (mSOFA), the Confusion, Urea, Respiratory Rate, Blood Pressure and Age (CURB-65) score, and Pneumonia Severity Index (PSI) were calculated with data from the emergency department. We used decision-curve analysis to evaluate the clinical usefulness of each score and the primary outcome was in-hospital mortality. MEASUREMENTS AND MAIN RESULTS: Of 6,874 patients, 442 (6.4%) died in-hospital. SIRS presented the worst discrimination, followed by qSOFA, CRB, mSOFA, CURB-65, and PSI. Overall, overestimation of in-hospital mortality and miscalibration was more evident for qSOFA and mSOFA. SIRS had lower net benefit than qSOFA and CRB, significantly increasing the risk of over-treatment and being comparable with the "treat-all" strategy. PSI had higher net benefit than mSOFA and CURB-65 for mortality, whereas mSOFA seemed more applicable when considering mortality/intensive care unit admission. Sepsis-3 flowchart resulted in better identification of patients at high risk of mortality. CONCLUSIONS: qSOFA and CRB outperformed SIRS and presented better clinical usefulness as prompt tools for patients with community-acquired pneumonia in the emergency department. Among the tools for a comprehensive patient assessment, PSI had the best decision-aid tool profile.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ranzani OT, Prina E, Menéndez R, et al. New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study. Am J Respir Crit Care Med. 2017. PMID: 28613918. doi:10.1164/rccm.201611-2262OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。